Related Experiment Video
Updated: Jul 18, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes
1Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA.
Background & Aims:
Mutations of c-K-ras occur commonly in colonic neoplasms. The aim of this study was to determine how c-K-ras mutations alter the responses to the chemopreventive agent sulindac.
Methods:
The parental rat intestinal cell line IEC-18 and c-K-ras-transformed derivatives were treated with sulindac sulfide. Cell cycle distribution was determined by flow-cytometric analysis (fluorescence-activated cell sorter), apoptosis by DNA fragmentation (laddering), flow cytometry, and microscopy, and changes in gene expression by immunoblotting.
Results:
Sulindac sulfide inhibited cell growth and induced apoptosis in a time- and dose-dependent manner more rapidly in and at lower concentrations in parental cells than ras-transformed cells. Expression of the sulindac sulfide arrested cells in G0/G1, but cells entered apoptosis throughout the cell cycle. Proapoptotic protein Bak was relatively high in untreated parental cells and increased markedly after sulindac sulfide but was low in untreated ras-transformed cells and did not increase after sulindac sulfide. Expression of other Bcl-2 family members was unchanged after sulindac sulfide. However, sulindac sulfide reduced levels of cyclin D1 protein and cyclin E- and cyclin D1-associated kinase activity.
Conclusions:
c-K-ras-transformed enterocytes are relatively resistant to sulindac sulfide-induced growth inhibition and apoptosis, which may result from specific reduction of bak expression.
Insights
Colorectal cancer cells with c-K-ras mutations show reduced sensitivity to the chemopreventive drug sulindac sulfide. This resistance may stem from decreased expression of the pro-apoptotic protein Bak.
Area of Science:
- Gastroenterology
- Molecular Biology
- Cancer Research
Background:
- c-K-ras mutations are frequent in colon neoplasms.
- Understanding their impact on cancer prevention is crucial.
Purpose of the Study:
- To investigate how c-K-ras mutations affect cellular response to sulindac, a chemopreventive agent.
- To elucidate the mechanisms underlying sulindac resistance in mutated cells.
Main Methods:
- Utilized rat intestinal cell line IEC-18 and its c-K-ras-transformed derivatives.
- Assessed cell cycle, apoptosis, and gene expression changes upon sulindac sulfide treatment.
- Employed flow cytometry, DNA fragmentation assays, and immunoblotting.
Main Results:
- Sulindac sulfide inhibited growth and induced apoptosis more effectively in parental cells than in ras-transformed cells.
- Ras-transformed cells exhibited lower levels of pro-apoptotic Bak protein, which did not increase with sulindac sulfide treatment.
- Sulindac sulfide reduced cyclin D1 protein and associated kinase activity in both cell types.
Conclusions:
- c-K-ras-transformed enterocytes display relative resistance to sulindac sulfide.
- This resistance is potentially linked to the specific downregulation of Bak expression.
Related Concept Videos
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...

